Gingrey, Green introduce ADAPT Act to safeguard public health

f t # e
Washington, D.C., Dec 12, 2013 | Jen Talaber (202.225.2931) | comments

Reps. Phil Gingrey, M.D., (R-GA), Gene Green (D-TX), G.K. Butterfield, (D-NC), Marsha Blackburn (R-TN), Diana DeGette (D-CO), Morgan Griffith (R-VA), Eliot Engel (D-NY), Anna Eshoo (D-CA), John Shimkus (R-IL), and Ed Whitfield (R-KY) today introduced The Antibiotic Development to Advance Patient Treatment (ADAPT) Act of 2013. This legislation is a successor to the GAIN Act, introduced by Gingrey, Green and others, and signed into law last year. The ADAPT Act advances drug development in order to combat the growing public health threat of “superbugs,” which the Center for Disease Control (CDC) warned of earlier this year.

Rep. Phil Gingrey, M.D.: “Since the GAIN Act was signed into law, it has played an important role in restoring antibiotic development. The ADAPT Act is an important next step in the effort to fight antimicrobial resistance, and I’m grateful for Congressman Green’s and my other colleagues’ efforts on this legislation. As a physician for more than 30 years, I understand the critical need for life-saving medical treatments. The ADAPT Act provides incentives for investment and innovation and is another step forward in developing treatments for patients with antibiotic-resistant infections.”

Rep. Gene Green: “I am proud to be joined by health policy leaders from both sides of the aisle in introducing this important bill, especially my friend Representative Phil Gingrey. “For decades, antibiotics have been taken for granted, but their effectiveness is waning and the pipeline for new drugs is running dry. We need to invest in new, effective antibiotic therapies in order to combat serious and life-threatening drug-resistant infections. The ADAPT Act, will build on the success of the GAIN Act, and serve as the next important step in advancing the development of new antibiotics.”

f t # e